Report

reporttype1Version of Safety Report ID1receivedateformat102transmissiondateformat102fulfillexpeditecriteria1Safety Report ID10133792serious1Date Last Updated28/04/2014receiptdateformat102companynumbBR-DSJP-DSJ-2014-106223occurcountryBRseriousnessother1duplicate1Date Received28/04/2014seriousnesshospitalization1transmissiondate12/12/2014primarysourcecountryBR

Primary Source

reportercountryBRqualification5

Patient

SexUnknown

Contents

Reaction
- 1)
- 2)
- 3)
- 4)
Drug

Reaction

1)

reactionmeddraversionpt17.0ReactionProstate cancerOutcomeRecovered/resolved

2)

reactionmeddraversionpt17.0ReactionNosocomial infectionOutcomeRecovered/resolved

3)

reactionmeddraversionpt17.0ReactionUrethral stenosisOutcomeRecovered/resolved

4)

reactionmeddraversionpt17.0ReactionBlood pressure increasedOutcomeNot recovered/not resolved

Drug

1)

drugcharacterization1medicinalproductBENICAR ANLOdrugseparatedosagenumb1drugintervaldosageunitnumb1drugintervaldosagedefinition804drugdosagetext40/10 MG, QDdrugdosageformTABLETdrugadministrationroute048drugindicationHYPERTENSIONdrugstartdateformat602drugstartdate//2005drugenddateformat602drugenddate//2010actiondrug1

2)

drugcharacterization2medicinalproductCLONAZEPAM NORTHIAdrugdosagetextUNKdrugadministrationroute065

3)

drugcharacterization2medicinalproductSERTRALINEdrugdosagetextUNKdrugadministrationroute065

openFDA Info on Medication

Application NumberANDA077670, ANDA077864, ANDA077397Brand NameSERTRALINEGeneric NameSERTRALINE, SERTRALINE HYDROCHLORIDEManufacturers Lupin Pharmaceuticals, Inc., Hikma Pharmaceuticals USA Inc., Exelan Pharmaceutic ... product_ndc 68180-351, 68180-352, 68180-353, 0143-9655, 0143-9656, 0143-9654, 76282-212, 762 ... Product TypeHUMAN PRESCRIPTION DRUGRouteORALActive IngredientsSERTRALINE HYDROCHLORIDERXCUI312938, 312940, 312941spl_id 78d3579a-260f-4bb2-95f2-8ee8a60fae18, f35de481-61af-428e-abb4-a267238b3959, 5c8d ... spl_set_id 42120ff8-b353-4632-9ea9-54de9a698724, f9641190-9151-4f7e-89ff-1e7a818c30ee, 2dac ... Package NDC 68180-351-06, 68180-351-08, 68180-351-09, 68180-351-01, 68180-351-03, 68180-352- ... UNIIUTI8907Y6X

Report Duplicate

duplicatesourceDAIICHIduplicatenumbBR-DSJP-DSJ-2014-106223

Receiver

receivertype6receiverorganizationFDA

Sender

sendertype2senderorganizationFDA-Public Use

Adverse Event Report

Report

Primary Source

Patient

Reaction

1)

2)

3)

4)

Drug

1)

2)

3)

openFDA Info on Medication

Report Duplicate

Receiver

Sender

Media

Newsletter

Follow us

Connect with us